Clinical Site Partners Orlando, Miami, Leesburg, Florida A NETWORK OF RESEARCH SITES CONDUCTING PHASE I-IV CLINICAL TRIALS Find a Research Site Near You  

Clinical Research Network Serving Florida

Sponsor / CRO Info

A large network of experienced investigators clinical research facilities, successful patient recruitment and retention strategies, and more.

Therapeutic Areas We Research

Women’s Health, Cardiology, Vaccines, Dermatology, Nephrology, Pediatric Pulmonology, and More!

Clinical Research Blog

Dr. Faisal A. Fakih explains the transmission of COVID-19

Dr. Faisal A. Fakih explains the transmission of COVID-19

Our lead PI and Medical Director – Dr. Faisal A. Fakih, who is conducting several COVID trials in our Winter Park, FL location, explains the transmission of COVID-19, in terms we can all understand. Thank you Dr. Fakih! To learn more about our enrolling COVID-19 trials in Winter Park, please visit our website: https://www.clinicalsitepartners.com/our-network/orlando/studies

Read More »
Regeneron Researcher Breaks Down Antibody Cocktail Given To President Trump

Regeneron Researcher Breaks Down Antibody Cocktail Given To President Trump

In a recent statement by Regeneron, they stated preclinical studies showed REGN-COV2 reduced the amount of virus and the time to alleviate symptoms in non-hospitalized patients with COVID-19 REGN-COV2 is the experimental medication which has recently garnered attention after it was administered to President Trump as part of his treatment for COVID-19. Regeneron is the

Read More »
Investigador de Regeneron dice que medicamento podría ser puente a la vacuna

Investigador de Regeneron dice que medicamento podría ser puente a la vacuna

Experto aclara dudas sobre el tratamiento recibido por presidente Donald Trump. REGN-COV2 es el medicamento experimental que ha recibido mucha atención recientemente tras ser dado al Presidente Trump como parte de su tratamiento contra el COVID-19. Regeneron es la compañía de biotecnología que desarrolló el coctel de anticuerpos que aún no ha recibido aprobación por

Read More »